These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
4. Summaries for patients. The blood pressure drug losartan appears to benefit the kidneys of people with type 2 diabetes who do not have high blood pressure. Ann Intern Med; 2003 Jul 15; 139(2):I24. PubMed ID: 12859179 [No Abstract] [Full Text] [Related]
5. Clinical characteristics of normotensive renal transplant recipients with microalbuminuria and effects of angiotensin II type I receptor antagonist on urinary albumin excretion. Satoh S, Horikawa Y, Kakinuma H, Tsuchiya N, Wang L, Kato T, Habuchi T. Int J Urol; 2004 Aug 15; 11(8):585-91. PubMed ID: 15285746 [Abstract] [Full Text] [Related]
6. Use of losartan in reducing microalbuminuria in normotensive patients with type-2 diabetes mellitus. Agha A, Bashir K, Anwar E. Nepal Med Coll J; 2007 Jun 15; 9(2):79-83. PubMed ID: 17899953 [Abstract] [Full Text] [Related]
7. Reduction of microalbuminuria by using losartan in normotensive patients with type 2 diabetes mellitus: A randomized controlled trial. Agha A, Amer W, Anwar E, Bashir K. Saudi J Kidney Dis Transpl; 2009 May 15; 20(3):429-35. PubMed ID: 19414946 [Abstract] [Full Text] [Related]
14. Long-term comparison of losartan and enalapril on kidney function in hypertensive type 2 diabetics with early nephropathy. Lacourcière Y, Bélanger A, Godin C, Hallé JP, Ross S, Wright N, Marion J. Kidney Int; 2000 Aug 15; 58(2):762-9. PubMed ID: 10916100 [Abstract] [Full Text] [Related]